KR102777327B1 - 발효 공정 - Google Patents

발효 공정 Download PDF

Info

Publication number
KR102777327B1
KR102777327B1 KR1020207020105A KR20207020105A KR102777327B1 KR 102777327 B1 KR102777327 B1 KR 102777327B1 KR 1020207020105 A KR1020207020105 A KR 1020207020105A KR 20207020105 A KR20207020105 A KR 20207020105A KR 102777327 B1 KR102777327 B1 KR 102777327B1
Authority
KR
South Korea
Prior art keywords
gly
ala
lys
ser
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207020105A
Other languages
English (en)
Korean (ko)
Other versions
KR20200116084A (ko
Inventor
필립 가반트
바쿠리 모하메드 엘
멜데렌 로렌스 반
Original Assignee
신굴론 에스.에이.
유니베르시테 리브레 드 브룩크젤즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신굴론 에스.에이., 유니베르시테 리브레 드 브룩크젤즈 filed Critical 신굴론 에스.에이.
Publication of KR20200116084A publication Critical patent/KR20200116084A/ko
Application granted granted Critical
Publication of KR102777327B1 publication Critical patent/KR102777327B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020207020105A 2017-12-19 2018-12-19 발효 공정 Active KR102777327B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17208600.1 2017-12-19
EP17208600 2017-12-19
PCT/EP2018/085941 WO2019121983A1 (en) 2017-12-19 2018-12-19 Fermentation process

Publications (2)

Publication Number Publication Date
KR20200116084A KR20200116084A (ko) 2020-10-08
KR102777327B1 true KR102777327B1 (ko) 2025-03-05

Family

ID=60781747

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207020105A Active KR102777327B1 (ko) 2017-12-19 2018-12-19 발효 공정

Country Status (7)

Country Link
US (1) US11932672B2 (enExample)
EP (1) EP3728292A1 (enExample)
JP (2) JP2021506328A (enExample)
KR (1) KR102777327B1 (enExample)
CN (1) CN111757890A (enExample)
BR (1) BR112020012543A2 (enExample)
WO (1) WO2019121983A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110564663B (zh) 2013-08-19 2023-03-10 辛格隆股份公司 微生物的受控生长
WO2019046577A1 (en) 2017-08-31 2019-03-07 Syngulon Sa METHODS AND COMPOSITIONS FOR THE PRODUCTION OF BACTERIOCIN AND ANTIMICROBIAL PEPTIDES
CN111757890A (zh) 2017-12-19 2020-10-09 辛格隆股份公司 发酵工艺
WO2019236761A1 (en) 2018-06-06 2019-12-12 Syngulon Sa Engineering antimicrobial peptides
BR112022001845A2 (pt) * 2019-08-19 2022-06-21 Univ Baylor Liberação probiótica de peptídeos antimicrobianos guiados
EP4038089A2 (en) * 2019-10-04 2022-08-10 University Of Plymouth Antimicrobial peptides
BR112022014917A2 (pt) * 2020-01-27 2023-02-14 General Probiotics Inc Composições incluindo bactérias probióticas para a expressão e secreção de enterocinas para controlar a enterite necrótica induzida por clostridia perfringens em animais de pecuária e métodos relacionados
WO2023041435A1 (en) * 2021-09-14 2023-03-23 Syngulon S.A. Bacteriocin for applications against mycobacterium
CN114478722B (zh) * 2022-02-09 2023-07-21 淮北师范大学 一种细菌素Bacin A1及其应用
CN117126925B (zh) * 2023-08-07 2024-06-07 中科枢密生物技术(武汉)有限公司 一种能够长期稳定保存的Crispr-Cas核酸检测试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150050253A1 (en) * 2013-08-19 2015-02-19 Syngulon Sa. Controlled growth of microorganisms

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107697T1 (de) 1986-03-26 1994-07-15 Genexpress Aps Biologische eindämmung.
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5300431A (en) 1991-02-26 1994-04-05 E. I. Du Pont De Nemours And Company Positive selection vector for the bacteriophage P1 cloning system
DE69233336T2 (de) * 1991-02-26 2005-03-31 Astrazeneca Ab Vektor
BE1006085A3 (fr) 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
US7176029B2 (en) 1992-07-31 2007-02-13 Universite Libre De Bruxelles Cloning and/or sequencing vector
US5549895A (en) 1993-05-17 1996-08-27 Iowa State University Research Foundation, Inc. Method and colicin composition for inhibiting Escherichia coli 0157:H7 in food products
JP2590761B2 (ja) 1994-11-22 1997-03-12 日本電気株式会社 Ｔａｂ式半導体装置およびｔａｂ式半導体装置を回路基板に接続する方法
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
PT937098E (pt) 1995-06-07 2002-12-31 Invitrogen Corp Clonagem recombinatoria in vitro utilizando locais de recombinacao modificados
WO1997008553A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Targeting of proteins to the cell wall of gram-positive bacteria
WO1997013401A1 (en) 1995-10-13 1997-04-17 Purdue Research Foundation Method for the production of hybrid plants
US5922583A (en) 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
AU8392698A (en) 1997-07-09 1999-02-08 Governors Of The University Of Alberta, The Novel bacteriocins, transport and vector system and method of use thereof
NZ504214A (en) 1997-10-24 2003-06-30 Invitrogen Corp Recombination cloning using nucleic acids having recombination sites
FR2770536B1 (fr) 1997-11-06 2001-09-21 Texel Nouveau plasmide non rcr apte a etre transfere dans des bact eries lactiques; utilisation comme outil de clonage et d'expression
US7183097B1 (en) 1998-05-07 2007-02-27 Universite Libre De Bruxelles Cytotoxin-based biological containment
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
EP1224304A4 (en) 1999-10-25 2005-04-06 Invitrogen Corp METHOD FOR MANIPULATING AND SEQUENCING NUCLEIC ACID MOLECULES BY TRANSPOSITION AND RECOMBINATION
WO2001042509A1 (en) 1999-12-10 2001-06-14 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
EP1111061A1 (en) 1999-12-20 2001-06-27 Universite Libre De Bruxelles Double selection vector
DE10038573A1 (de) 2000-08-03 2002-02-21 Mpb Cologne Gmbh Molecular Pla Verfahren zur Selektion auf Wirtszellen mit eliminierten DNA-Sequenzen
EP1362110B1 (en) 2001-02-23 2012-09-12 Université Libre de Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
AU2003213889B2 (en) 2002-03-19 2008-12-04 Universite Libre De Bruxelles Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
EP1556485B1 (en) 2002-09-03 2008-01-09 Université Libre de Bruxelles Reversible, parallel and multitask cloning method and kit
US9309518B2 (en) 2002-09-03 2016-04-12 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
WO2009011940A2 (en) * 2007-04-06 2009-01-22 University Of Maryland, Baltimore Microcin h47 plasmid selection system
WO2010060057A1 (en) 2008-11-22 2010-05-27 Southern Illinois University Edwarsville Bacteriocin based methods to control lactic acid bacterial growth
US20100330041A1 (en) 2009-05-27 2010-12-30 Bayrock Dennis P Viral-based antimicrobial agent use in ethanol production
US8476048B2 (en) 2010-12-17 2013-07-02 E I Du Pont De Nemours And Company Xylose utilizing zymomonas mobilis with improved ethanol production in biomass hydrolysate medium
GB201021795D0 (en) * 2010-12-21 2011-02-02 Msd Biolog Uk Ltd Expression Process
DK2543255T4 (da) 2011-07-04 2023-03-20 Dsm Ip Assets Bv Antilisteriel blandet kultur og fremgangsmåde til fremstilling af ost
US8697426B2 (en) 2012-06-15 2014-04-15 E I Du Pont De Nemours And Company Contaminant control in Zymomonas fermentation using virginiamycin
US20140148379A1 (en) 2012-11-28 2014-05-29 Mei Liu Control of Unwanted Bacteria in Fermentation Systems with Bacteriocin
US8846357B2 (en) 2012-12-20 2014-09-30 E I Du Pont De Nemours And Company Stabilized chlorine dioxide for contamination control in Zymomonas fermentation
WO2019046577A1 (en) 2017-08-31 2019-03-07 Syngulon Sa METHODS AND COMPOSITIONS FOR THE PRODUCTION OF BACTERIOCIN AND ANTIMICROBIAL PEPTIDES
CN111757890A (zh) 2017-12-19 2020-10-09 辛格隆股份公司 发酵工艺
WO2019236761A1 (en) 2018-06-06 2019-12-12 Syngulon Sa Engineering antimicrobial peptides
WO2020104662A1 (en) 2018-11-22 2020-05-28 Syngulon S.A. Peptides for inducing bacteriocin synthesis and methods to identify and/or select and/or optimize the same
US20230416797A1 (en) 2020-11-10 2023-12-28 Syngulon Sa. Modulating antimicrobial peptide half-life
WO2022104320A1 (en) 2020-11-10 2022-05-19 Syngulon Sa. Control of microorganisms in microbial communities

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150050253A1 (en) * 2013-08-19 2015-02-19 Syngulon Sa. Controlled growth of microorganisms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Applied and environmental microbiology, Vol.62, pp.4450-4460 (1996)

Also Published As

Publication number Publication date
WO2019121983A1 (en) 2019-06-27
JP2024105566A (ja) 2024-08-06
US20210070812A1 (en) 2021-03-11
KR20200116084A (ko) 2020-10-08
US11932672B2 (en) 2024-03-19
BR112020012543A2 (pt) 2021-02-23
EP3728292A1 (en) 2020-10-28
CN111757890A (zh) 2020-10-09
JP2021506328A (ja) 2021-02-22

Similar Documents

Publication Publication Date Title
KR102777327B1 (ko) 발효 공정
KR102863181B1 (ko) 윌슨병을 치료하기 위한 유전자 치료
AU774643B2 (en) Compositions and methods for use in recombinational cloning of nucleic acids
AU2019375975B2 (en) Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons
AU2016333886B2 (en) Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
US20250135031A1 (en) Single-vector gene construct comprising insulin and glucokinase genes
DK2768848T3 (en) METHODS AND PROCEDURES FOR EXPRESSION AND SECRETARY OF PEPTIDES AND PROTEINS
AU2019257708B2 (en) Expression of human FOXP3 in gene edited T cells
KR20210149060A (ko) Tn7-유사 트랜스포존을 사용한 rna-유도된 dna 통합
CN116083398B (zh) 分离的Cas13蛋白及其应用
CN109661403A (zh) 前导序列修饰的葡糖淀粉酶多肽和具有增强的生物产物产生的工程化的酵母菌株
CN109923211A (zh) Pd-1归巢核酸内切酶变体、组合物及使用方法
TW202536186A (zh) 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
CN115323000B (zh) 使用细胞分裂基因座控制细胞增殖的工具和方法
KR102409420B1 (ko) 형질전환 생물체 선별용 마커 조성물, 형질전환 생물체 및 형질전환 방법
KR20230038460A (ko) 동종 종양 세포 백신
US20250213726A1 (en) Therapeutic adeno-associated virus using codon optimized nucleic acid encoding alpha-glucosidase (gaa) for treating pompe disease, with signal peptide modifications
AU2023412431A1 (en) Complex and use thereof
KR20230123115A (ko) Ace-2 변이체 및 이의 용도
HK40082332A (zh) 使用细胞分裂基因座控制细胞增殖的工具和方法
HK40041692A (en) Expression of human foxp3 in gene edited t cells
PL228024B1 (pl) Zestaw wektorów ekspresyjnych

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200710

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20211217

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20231127

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20241125

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250228

End annual number: 3

Start annual number: 1

PG1601 Publication of registration